Intradermal Injection video | Perpendicular Injection with Uneedle

Our intradermal lead product Bella-mu simplifies intradermal administration of up to 1 mL, offering an easier learning curve compared to the Mantoux technique. It’s an ideal solution for companies developing cancer vaccines that seek enhanced immune responses, reduced antigen requirements, and improved patient compliance. Bella-mu is particularly effective for vaccines utilizing neoantigens, whole-tumor cells, mRNA, DNA, peptides, viral vectors, or dendritic cells.